Trials / NCT02837640
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
Status unknown Phase 2 Drug / neuroprotection
- Sponsor
- Beirut Eye Specialist Hospital
- Treatment
- levodopa-carbidopa
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 10 Years to 65 Years
- Enrollment
- 50 participants
- Started
- 2016-06
- Main results expected
- 2017-06
- Results posted
- Not yet
- Record last updated
- 2016-07-19
What the study is testing
The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.
Where it runs
Lebanon (1)
- Beirut Eye Specialist Hospital, Beirut (recruiting now)